The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: a Retrospective Study in a Single Center

The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: a Retrospective Study in a Single Center

Purpose: Nowadays, myelofibrosis can be cured only by allogeneic hematopoietic stem cell transplantation (allo-HSCT), but the transplantation experience is very limited worldwide. We retrospectively investigated the treatment outcome of myelofibrosis patients post allo-HSCT at National Taiwan Univer...

Full description

Bibliographic Details
Main Authors: Mei-Fang Hou, Hsin-An Hou, Chien-Ting Lin, Chi-Cheng Li, Ming Yao, Jie-Yang Jhuang, Chung-Wu Lin, Bor-Sheng Ko, Shang-Yi Huang, Wen-Chien Chou, Yao-Chang Chen, Hwei-Fang Tien, Jih-Luh Tang
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-03-01
Series:Journal of Cancer Research and Practice
Subjects:
myelofibrosis
allogeneic hematopoietic stem cell transplantation
infection
prognosis
graft-versus-host disease
Online Access:http://www.sciencedirect.com/science/article/pii/S231130061630057X

Internet

http://www.sciencedirect.com/science/article/pii/S231130061630057X

Similar Items